A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Recruiting · NCT07230652 · Registry updated 2025-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 1 | 2025-11-19 | NCT07230652 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Luye Pharma Group Ltd. | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing AnDing Hospital Capital Medical University | Beijing | China | 4 |